Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
0.9152
+0.0432 (4.95%)
Oct 28, 2026, 1:40 PM EDT - Market open
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $117.17 million as of October 28, 2026. It is the 24,358th most valuable company in the world and the 4,001st biggest in the United States. Its market cap has decreased by 47.83% in one year.
Market Cap
117.17M
Enterprise Value
114.93M
1-Year Change
-47.83%
Global Rank
Country Rank
#4,001 United States
Category
ChartMarket Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has decreased from $145.96M to $117.17M, a decrease of -19.72%. That is a compound annual growth rate of -4.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 117.17M | -33.82% |
| Dec 31, 2025 | 177.05M | 133.12% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
| Oct 21, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Armata Pharmaceuticals | 135.34M |
| AN2 Therapeutics | 133.96M |
| Jyong Biotech | 131.39M |
| Spruce Biosciences | 129.76M |
| Nkarta | 128.21M |
| Retension Pharmaceuticals | 127.06M |
| Outlook Therapeutics | 126.42M |
| Anavex Life Sciences | 123.29M |